Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

DXCM holding history

Dexcom Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings

Shares (Q2 2026)
6,065,779
Value
$408.5M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of DXCM by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,065,779$408.5M0.1%+1,715,820+39.4%AddedHolders
Q1 20264,349,959$273.2M<0.1%+2,426,179+126.1%AddedHolders
Q4 20251,923,780$127.7M<0.1%−1,032,342−34.9%ReducedHolders
Q3 20252,956,122$198.9M<0.1%+1,023,431+53.0%AddedHolders
Q2 20251,932,691$168.7M<0.1%−61,819−3.1%ReducedHolders
Q1 20251,994,510$136.2M<0.1%+46,824+2.4%AddedHolders
Q4 20241,947,686$151.5M<0.1%+535,372+37.9%AddedHolders
Q3 20241,412,314$94.7M<0.1%+215,023+18.0%AddedHolders
Q2 20241,197,291$135.7M<0.1%+84,628+7.6%AddedHolders
Q1 20241,112,663$154.3M0.1%+84,435+8.2%AddedHolders
Q4 20231,028,228$127.6M0.1%−45,110−4.2%ReducedHolders
Q3 20231,073,338$100.1M<0.1%+126,531+13.4%AddedHolders
Q2 2023946,807$121.7M0.1%+335,383+54.9%AddedHolders
Q1 2023611,424$71.0M<0.1%−54,676−8.2%ReducedHolders
Q4 2022666,100$75.4M<0.1%+317,190+90.9%AddedHolders
Q3 2022348,910$28.1M<0.1%−92,903−21.0%ReducedHolders
Q2 2022441,813$32.9M<0.1%−71,075−13.9%ReducedConverted for a 4-for-1 splitHolders
Q1 2022128,222$65.6M<0.1%−57,116−30.8%ReducedHolders
Q4 2021185,338$99.5M<0.1%+6,883+3.9%AddedHolders
Q3 2021178,455$97.6M<0.1%+37,055+26.2%AddedHolders
Q2 2021141,400$60.4M<0.1%+14,795+11.7%AddedHolders
Q1 2021126,605$45.5M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.